Literature DB >> 18679797

Deamidation of gliadin peptides in lamina propria: implications for celiac disease.

H Skovbjerg1, D Anthonsen, E Knudsen, H Sjöström.   

Abstract

Activation of small intestinal gluten-reactive CD4(+) T-cells is a critical event in celiac disease. Deamidation of specific glutamine residues by tissue transglutaminase enhances the binding of T-cell activating gliadin epitopes to DQ2, increasing T-cell recognition. Our purpose was to investigate whether deamidated gliadin epitopes can be generated in the small intestinal mucosa by tissue transglutaminase and to characterize the location of the process. Intestinal explants from pig intestine and frozen biopsy slices from human and rat intestine were incubated with alpha-gliadin peptides containing the immunodominant motif. Monoclonal antibodies specifically recognizing the non-deamidated and/or the deamidated epitope were used for immunofluorescence studies. We conclude that endogenous tissue transglutaminase can mediate extracellular deamidation of gliadin peptides in the lamina propria. Gliadin peptides with more than one recognition site can be simultaneously cross-linked and deamidated extracellularly in the lamina propria, and might be of importance for the antibody response seen in untreated celiac disease patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18679797     DOI: 10.1007/s10620-008-0450-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.

Authors:  O Molberg; S McAdam; K E Lundin; C Kristiansen; H Arentz-Hansen; K Kett; L M Sollid
Journal:  Eur J Immunol       Date:  2001-05       Impact factor: 5.532

2.  Role of tissue transglutaminase in gliadin binding to reticular extracellular matrix and relation to coeliac disease autoantibodies.

Authors:  H Uhlig; A A Osman; I D Tanev; J Viehweg; T Mothes
Journal:  Autoimmunity       Date:  1998       Impact factor: 2.815

3.  Identification of tissue transglutaminase as the autoantigen of celiac disease.

Authors:  W Dieterich; T Ehnis; M Bauer; P Donner; U Volta; E O Riecken; D Schuppan
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

4.  Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease.

Authors:  W Dieterich; B Esslinger; D Trapp; E Hahn; T Huff; W Seilmeier; H Wieser; D Schuppan
Journal:  Gut       Date:  2005-09-27       Impact factor: 23.059

5.  Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease.

Authors:  Hanne Skovbjerg; Claus Koch; Dorit Anthonsen; Hans Sjöström
Journal:  Biochim Biophys Acta       Date:  2004-11-05

Review 6.  Coeliac disease: dissecting a complex inflammatory disorder.

Authors:  Ludvig M Sollid
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

7.  Coeliac disease: in vivo toxicity of the putative immunodominant epitope.

Authors:  J S Fraser; W Engel; H J Ellis; S J Moodie; E L Pollock; H Wieser; P J Ciclitira
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

8.  Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides.

Authors:  Burkhard Fleckenstein; Shuo-Wang Qiao; Martin R Larsen; Günther Jung; Peter Roepstorff; Ludvig M Sollid
Journal:  J Biol Chem       Date:  2004-01-27       Impact factor: 5.157

9.  Gliadin is a good substrate of several transglutaminases: possible implication in the pathogenesis of coeliac disease.

Authors:  H Skovbjerg; O Norén; D Anthonsen; J Moller; H Sjöström
Journal:  Scand J Gastroenterol       Date:  2002-07       Impact factor: 2.423

10.  Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease.

Authors:  Carla Esposito; Francesco Paparo; Ivana Caputo; Raffaele Porta; Virginia M Salvati; Giuseppe Mazzarella; Salvatore Auricchio; Riccardo Troncone
Journal:  Am J Gastroenterol       Date:  2003-08       Impact factor: 10.864

View more
  2 in total

1.  Discerning the role of Bacteroides fragilis in celiac disease pathogenesis.

Authors:  E Sánchez; J M Laparra; Y Sanz
Journal:  Appl Environ Microbiol       Date:  2012-07-06       Impact factor: 4.792

2.  Constitutive Differential Features of Type 2 Transglutaminase in Cells Derived from Celiac Patients and from Healthy Subjects.

Authors:  Gaetana Paolella; Merlin Nanayakkara; Silvia Sposito; Marilena Lepretti; Salvatore Auricchio; Carla Esposito; Maria Vittoria Barone; Stefania Martucciello; Ivana Caputo
Journal:  Int J Mol Sci       Date:  2020-02-12       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.